Both are titans of medical devices, but Medtronic edges out Boston Scientific in sheer scale and portfolio breadth. BSc punches back hard in cardiology and endoscopy niches.
Medtronic's original mission statement from 1960 pledged to 'restore patients to full, productive lives' — bold words for a company that started in a garage with $500 and a borrowed soldering iron.
You want the broadest possible medical device portfolio under one roof
Medtronic spans neurology, cardiac, diabetes, surgical robotics, and ENT — it's basically a medical device mall.
→ Pick MedtronicYou want cutting-edge electrophysiology or endoscopy solutions
Boston Scientific's FARAPULSE and endoscopy lineup are best-in-class and outpace Medtronic in these niches.
→ Pick Boston ScientificYou're a hospital system negotiating a single-vendor contract for maximum coverage
Medtronic's sheer breadth of 20+ divisions makes consolidated procurement far easier.
→ Pick MedtronicYou're an investor looking for a higher-growth, more focused med-tech bet
Boston Scientific has posted faster revenue growth rates recently, with a leaner, more targeted strategy.
→ Pick Boston Scientific